OPRX - OptimizeRx Corporation
| Previous Close | 15.11 |
| Open | 15.01 |
| Bid | 14.67 x 1100 |
| Ask | 14.72 x 1300 |
| Day's Range | 14.57 - 15.15 |
| 52 Week Range | 8.92 - 18.39 |
| Volume | 50,707 |
| Avg. Volume | 121,330 |
| Market Cap | 180.13M |
| Beta (3Y Monthly) | 0.14 |
| PE Ratio (TTM) | 419.14 |
| EPS (TTM) | 0.04 |
| Earnings Date | May 11, 2017 - May 12, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.92 |
- Simply Wall St.•8 days ago
Could The OptimizeRx Corporation (NASDAQ:OPRX) Ownership Structure Tell Us Something Useful?
The big shareholder groups in OptimizeRx Corporation (NASDAQ:OPRX) have power over the company. Institutions often own...
- Benzinga•21 days ago
18 Stocks Joining The Russell Indices
The Russell 2000 Index is a small-cap stock market index that includes the bottom 2,000 companies found in the Russell 3000 index. The Russell Microcap Index includes the 1,000 smallest securities found ...
- Zacks•21 days ago
Top Ranked Growth Stocks to Buy for June 28th
Top Ranked Growth Stocks to Buy for June 28th
- GlobeNewswire•24 days ago
OptimizeRx Set to Join Russell Microcap® and 3000® Indexes
OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell Microcap® and 3000® Indexes at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the U.S. market opens on July 1, according to a preliminary list of additions posted June 21. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “We are honored to be included in the Russell Indexes,” said OptimizeRx CEO, William Febbo.
- Zacks•28 days ago
Red Hat's (RHT) Earnings & Revenues Beat Estimates in Q1
Red Hat's (RHT) first-quarter fiscal 2020 results benefit from strengthening subscription revenues and solid momentum with large deals.
- Zacks•last month
The Zacks Analyst Blog Highlights: Malibu Boats, MEDIFAST, OptimizeRx, Synergy Resources and Pioneer Natural
The Zacks Analyst Blog Highlights: Malibu Boats, MEDIFAST, OptimizeRx, Synergy Resources and Pioneer Natural
- GlobeNewswire•last month
OptimizeRx to Participate at the 5th Annual ROTH London Conference on June 17-19, 2019
OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has been invited to participate in the ROTH London Conference being held on June 17-19, 2019 at the Dorchester Hotel in London, U.K. The ROTH London Conference will give investors extensive interaction and one-on-one/small group meetings with management teams from about 50 small/mid-cap companies in the technology, cleantech and industrial sectors, and provide in-depth insights into each of them.
- Zacks•last month
Open Text (OTEX) Soars to 52-Week High, Time to Cash Out?
Open Text (OTEX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- GlobeNewswire•last month
OptimizeRx Launches New Growth Phase Immediately Following Addition of Chief Commercial Officer
OptimizeRx Corp. (OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has added three senior sales executives to its rapidly growing commercial team. The new hires demonstrate the company’s focus on driving growth and expanding its enterprise-level offerings. “Todd, Eze and Adam are each proven commercial sales leaders with strong records of delivering enterprise-level solutions and addressing unmet needs across the care continuum,” said Steve Silvestro, the company’s recently added chief commercial officer. According to a recent PWC study, 52 percent of consumers with a high deductible health plan say it would be hard to meet their deductible.
- Thomson Reuters StreetEvents•last month
Edited Transcript of OPRX earnings conference call or presentation 8-May-19 8:30pm GMT
Q1 2019 OPTIMIZERx Corp Earnings Call
- Zacks•last month
The Zacks Analyst Blog Highlights: OptimizeRx, eHealth, Strategic Education, Hibbett Sports and PC-Tel
The Zacks Analyst Blog Highlights: OptimizeRx, eHealth, Strategic Education, Hibbett Sports and PC-Tel
- GlobeNewswire•last month
OptimizeRx Announces Pricing of Public Offering of Common Stock
OptimizeRx Corporation (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering of 1,538,500 shares of its common stock, at a public offering price of $13.00 per share. The gross proceeds to OptimizeRx from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by OptimizeRx, are expected to be approximately $20.0 million. In connection with the offering, OptimizeRx granted the underwriters a 30-day option to purchase up to an additional 230,775 shares of its common stock at the public offering price, less the underwriting discount and commissions.
- Zacks•last month
5 Stocks Likely to Fly High on Powell's Rate Cut Hint
Powell's statement is in sharp contrast to his aggressive monetary stance in 2018 and a steady monetary policy for 2019, which he reaffirmed last month.
- GlobeNewswire•last month
OptimizeRx Announces Proposed Public Offering of Common Stock
OptimizeRx Corporation (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering of shares of its common stock. In connection with the offering, OptimizeRx expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering on the same terms and conditions. All shares to be sold in the offering are to be sold by OptimizeRx.
- GlobeNewswire•2 months ago
OptimizeRx to Participate at Investor Conferences in June
ROCHESTER, Mich., May 31, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to.
- Zacks•2 months ago
The Zacks Analyst Blog Highlights: OptimizeRx, Match, OSI and Marchex
The Zacks Analyst Blog Highlights: OptimizeRx, Match, OSI and Marchex
- Zacks•2 months ago
5 Tech Stocks Up in May Despite Stock Market Mayhem
Wall Street bull run, which continued in the first four months of this year and recorded the best start in 30 years, halted in May.
- Zacks•2 months ago
OptimizeRx Corporation (OPRX) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in OptimizeRx Corporation (OPRX).
- Zacks•2 months ago
The Zacks Analyst Blog Highlights: OptimizeRx, Match, Cubic, PCTEL and Diodes
The Zacks Analyst Blog Highlights: OptimizeRx, Match, Cubic, PCTEL and Diodes
- Simply Wall St.•2 months ago
Is OptimizeRx Corporation's (NASDAQ:OPRX) Capital Allocation Ability Worth Your Time?
Today we are going to look at OptimizeRx Corporation (NASDAQ:OPRX) to see whether it might be an attractive investment...
- GlobeNewswire•2 months ago
OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share
ROCHESTER, Mich., May 08, 2019 -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the.
- ACCESSWIRE•2 months ago
OptimizeRx Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 8, 2019 / OptimizeRx Corp. (NASDAQ: OPRX ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time. ...
